Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of DER 45-EV Gel to Treat Rosacea

ClinicalTrials.gov ID: NCT00940992

Public ClinicalTrials.gov record NCT00940992. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Dose-Range Study of DER 45 EV Gel, 1% and 5%, and Vehicle Gel in the Treatment of Rosacea

Study identification

NCT ID
NCT00940992
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sol-Gel Technologies, Ltd.
Industry
Enrollment
92 participants

Conditions and interventions

Conditions

Interventions

  • DER 45 EV Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2011
Primary completion
Aug 31, 2012
Completion
Dec 31, 2012
Last update posted
Jan 8, 2015

2012 – 2013

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Baumann Cosmetic & Research Institute Miami Florida 33140
FXM Research Corp Miami Florida 33175
Augusta Centre for Dermatology and Skin Augusta Georgia 30909
Minnesota Clinical Study Center Fridley Minnesota 55432
Skin Search of Rochester, Inc Rochester New York 14623
Tennessee Clinical Research Center Nashville Tennessee 37215
DermResearch, Inc Austin Texas 78759
J & S Studies, Inc College Station Texas 77840
Premier Clinical Research Spokane Washington 99204
Madison Skin and Research, Inc Madison Wisconsin 53719

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00940992, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00940992 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →